Recruiting
Phase 1

CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission

Sponsor:

City of Hope Medical Center

Code:

NCT05707273

Conditions

B Acute Lymphoblastic Leukemia

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Autologous Anti-CD19 CAR-expressing T Lymphocytes

Biospecimen Collection

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Fludarabine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information